Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection.
Cowan J, Pandey S, Filion LG, Angel JB, Kumar A, Cameron DW.
Clin Exp Immunol. 2012 Feb;167(2):317-29. doi: 10.1111/j.1365-2249.2011.04520.x.
Related citations
The in vivo immunomodulatory effect of recombinant tumour necrosis factor-alpha in guinea pigs vaccinated with Mycobacterium bovis bacille Calmette-Guérin.
Kramp JC, McMurray DN, Formichella C, Jeevan A.
Clin Exp Immunol. 2011 Jul;165(1):110-20. doi: 10.1111/j.1365-2249.2011.04406.x. Epub 2011 May 5.
The death-promoting molecule tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is not required for the development of peripheral lymphopenia or granuloma necrosis during infection with virulent Mycobacterium avium.
Borges M, Rosa GT, Appelberg R.
Clin Exp Immunol. 2011 Jun;164(3):407-16. doi: 10.1111/j.1365-2249.2011.04385.x. Epub 2011 Apr 6.
Autophagy in the immune response to tuberculosis: clinical perspectives.
Ní Cheallaigh C, Keane J, Lavelle EC, Hope JC, Harris J.
Clin Exp Immunol. 2011 Jun;164(3):291-300. doi: 10.1111/j.1365-2249.2011.04381.x. Epub 2011 Mar 25. Review.
Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation.
Toossi Z, Hirsch CS, Wu M, Mayanja-Kizza H, Baseke J, Thiel B.
Clin Exp Immunol. 2011 Mar;163(3):333-8. doi: 10.1111/j.1365-2249.2010.04269.x.
Induction of β-defensins by l-isoleucine as novel immunotherapy in experimental murine tuberculosis.
Rivas-Santiago CE, Rivas-Santiago B, León DA, Castañeda-Delgado J, Hernández Pando R.
Clin Exp Immunol. 2011 Apr;164(1):80-9. doi: 10.1111/j.1365-2249.2010.04313.x. Epub 2011 Jan 14.
CCL20 is overexpressed in Mycobacterium tuberculosis-infected monocytes and inhibits the production of reactive oxygen species (ROS).
Rivero-Lezcano OM, González-Cortés C, Reyes-Ruvalcaba D, Diez-Tascón C.
Clin Exp Immunol. 2010 Nov;162(2):289-97. doi: 10.1111/j.1365-2249.2010.04168.x. Epub 2010 Sep 1.
Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis.
Castañeda-Delgado J, Hernández-Pando R, Serrano CJ, Aguilar-León D, León-Contreras J, Rivas-Santiago C, Méndez R, González-Curiel I, Enciso-Moreno A, Rivas-Santiago B.
Clin Exp Immunol. 2010 Sep;161(3):542-50. doi: 10.1111/j.1365-2249.2010.04199.x.
Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis.
Denholm JT, McBryde ES, Eisen DP.
Clin Exp Immunol. 2010 Oct;162(1):84-90. doi: 10.1111/j.1365-2249.2010.04221.x. Epub 2010 Aug 19. Review.
Impaired host defence against Mycobacterium avium in mice with chronic granulomatous disease.
Fujita M, Harada E, Matsumoto T, Mizuta Y, Ikegame S, Ouchi H, Inoshima I, Yoshida S, Watanabe K, Nakanishi Y.
Clin Exp Immunol. 2010 Jun;160(3):457-60. Epub 2010 Jan 19.
How tumour necrosis factor blockers interfere with tuberculosis immunity.
Harris J, Keane J.
Clin Exp Immunol. 2010 Jul 1;161(1):1-9. Epub 2010 May 18. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on